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The obesity problem is a global epidemic of ever increas-
ing proportions. Because of a number of different reasons
many nations, in developed and developing countries, deal
with this problem. While the U.S.A. stand in “pole posi-
tion”, in Europe the uncontrolled diffusion of sweet snacks
is responsible for children obesity, in China the diminished
numbers of bikers in favour of car drivers, in Oceania the
success of “fast food” instead of the traditional fruit con-
sumption are considered as causes of this phenomenon.
All in all, according to reliable statistics, 1.5 billion peo-
ple all over the globe are obese: globesity.
Taking care of all these people accounts for 2-8% of all
the national medical expenses, as much as it takes for all
tumours, with the added difference that expenses for obe-
sity grow by 25 % every three years.
Further, mortality for obesity is three times the com-
pounded mortality of colon and breast cancers.
Obese individuals have a life expectancy approximately
shortened by 10-15 %, because of diabetes, cardiovascular dis-
eases, hypertension, cancer etc. One important and under-
valued problem is the augmented frequency of many different
malignant tumours found in the USA and Canadian obese
population as reported in the “New England Journal of Med-
icine” and found by us in the Italian obese population
Surgery in obese patients may reduce sanitary costs by
45% after 5 years. U.S.A. statistics show that, three years
and a half after surgery, operated patients cost less than non
operated patients.
At the same time mini invasive laparoscopic surgery,
during the last 20 years, has had a tremendous diffusion
world wide.
The combination of these two factors, obesity and lapa-
roscopy, determined a “critical mass” which resulted in the
explosion of bariatric surgery, with an exponential growth
in the last 10 years. The advantages of laparoscopic surgery
were greatly stressed in bariatric surgery.
Early mobilization and early recovery of G-E functions,
peculiar to laparoscopic surgery, are advantageous to all
patients but, even more so, in morbidly obese patients which
are high risk patients.
The great compliance of patients to bariatric laparoscopic
surgery caused in the U.S.A. a jump from 10.000 procedures
per year from the seventies to the nineties in the last cen-
tury, to 250.000 procedures during the last year.
Standardization of surgical techniques was an added rea-
son for the success of laparoscopy. The EAES Consensus
Conference in 2004 and the Consensus Statement of ACS
in 2005 indicated 4 types of standard surgical procedures:
adjustable gastric banding, vertical banded gastroplasty, gas-
tric by-pass, bilio-pancreatic diversion. 
Indications to surgery must be based on reasonable expec-
tations from the surgeon and from the patient. On this regard
the psychiatric/psychological interview is of the outmost
importance to avoid vain hopes and bitter disappointment.
At present internationally accepted and established precise cri-
teria must be considered to indicate bariatric surgery. 
Once surgery is indicated, which kind of operation
should be chosen? Over the years, many different proce-
dures, with a variety of rational basis, have been proposed.
The first significant contribution of surgery to the solu-
tion of the obesity problem was the intestinal bypass pro-
posed and performed by Linner, Kremer and Nelson in
1954. In 1963 Payne standardized the jejunal-ileal by pass.
The procedure determines a very effective and indiscrimi-
nate malabsorption by reducing to 30 cm the functioning
(digestion and absorption) small intestine.
However the early and unquestionable effect of surgery was
due to very significant physio-pathological changes with severe
side effects, in particular severe liver sequalae, even cirrhosis.
All major surgical societies consider this procedure banned.
At present there are three groups of standard surgical pro-
cedures, internationally accepted:
– restrictive procedures, laparoscopic adjustable silicone
gastric banding (LASGB) and vertical banded gastroplasty
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GRANDES TEMAS: OBESIDADE
Complications of GBP include haemorrhage (0.8-3.8%),
fistulization (0.8-3.6%) and strictures (1.6-5.8%), mainly
involving the gastro-jejunal anastomosis in the immediate
postoperative period.
In the long run internal hernias occur with an incidence
between 0.6 and 6% in different literature reports. The
pathogenesis is due to the incarceration of small bowel in
the surgery induced mesenteric defects, which become more
hazardous when visceral fat diminishes significantly.
The mechanism of action of this procedure involves gastric
restriction during the first post-operative period. However the
two main patho-genetic factors are: decreased appetite and
increased satiety which are tied to the hormones ghrelin pro-
duced by the stomach and PYY, stimulated by early arrival of
non processed food to the ileum. The alimentary exclusion of
the gastric body and fundus determines low levels of ghrelin,
hormone of appetite, and flattens its circadian rhythm: hunger
and daily meals frequency are reduced.
During the last few years great attention has been given to
the anti-diabetic effect of GBP. This effect has a very rapid
onset and is independent from weight loss suggesting the
presence of a hormonal mechanism.
Two mechanisms have been hypothesized: the Foregut
hypothesis and the Hindgut hypothesis.
In 1998 Paries foresaw a role for the duodenum-jejunum
in the pathogenesis of diabetes mellitus (2 D.M.).
In 2004 Rubino and Gagner pinpointed a number of
early hormonal effects of GBP.
In 2006 again Rubino elucidated, experimentally, the role
of duodenal exclusion in controlling 2 D.M. hypothesising
the presence of an anti-incretin substance secretion.
According to the hindgut hypothesis unmodified food
reaching the terminal ileum stimulates ileum L-cells to
secrete GLP – 1.
Finally the two main types of malabsorptive procedures
are: BPD and BPD – DS.
BPD was conceived in 1972 and performed in man in
1976 by Scopinaro.
In extreme synthesis Scopinaro obtained a high malab-
sorptive effect with minimal malnutrition consequences.
Patho-physiology of BPD is related to two factors: - a 50
cm common channel where mixing of food with the bilio-
pancreatic secretion occurs with diminished fat absorption
and diminished caloric intake; - a 200-250 cm alimentary
channel in which proteins, calcium and glicids are absorbed
lessening malnutrition problems. 
(VGB); – malabsorptive procedures, bilio-pancreatic diversion
(BPD and its modification with the so-called “duodenal
switch” (BPD-DS); - metabolic procedures, gastric by pass
(GBP).
VBG, once the procedure of choice, is almost completely
abandoned in the U.S.A., and is in declining popularity in
Europe.
LASGB was the first bariatric procedure to be performed
by laparoscopy and it is now the most frequently used in
Europe, with over 150.000 cases.
The reasons for LASGB popularity are: - it is a simple
procedure with very few operative and post operative com-
plications; - it is easily reversible, in most cases by
laparoscopy; - it is effective in 70% of cases and even more
when selection of patients is very accurate.
L.A.S.G.B. on one hand presents the lowest incidence of
operative and post-operative complications, but it has the
highest incidence of late complications requiring a surgical
procedure.
Major complications are: band migration into the stomach
due to erosion of the gastric wall; pouch dilatation due to
slippage or technical faults. However these complications
almost always do not represent emergency situations and are
dealt electively.
The treatment for the gastric pouch dilatation is the com-
plete band desufflation (conservative treatment), followed
by a progressive insufflation. The failure of the conservative
treatment makes it necessary to reposition or to remove the
prosthesis. To prevent this kind of complication it is better
to create a virtual pouch above the “bursa omentalis” and to
fix the prosthesis using gastro-gastric sutures.
The incidence rate of the gastric erosion is between 1,6%
and 6,3%, considering several clinical experiences. Solution
in most cases is mini invasive surgery: laparoscopic, endo-
scopic or combined laparoscopic-endoscopic.
Clinical results, after LASGB, are considered satisfactory
(BMI below 35) in 70-80 % of cases. The best results are
obtained in non super obese young women without ali-
mentary disorders like BED or sweet eating.
GBP represents 70% of all bariatric procedures in the
U.S.A.
GBP determines a EWL of 60% in the long period (over
14 years), cures co-morbidities like diabetes, hypertension
etc. in 80-90% of cases and has a low re- intervention rate.
For all these reasons GBP in the USA is considered the gold
standard in the treatment of morbid obesity.
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and psychological profile of alimentary behaviour. Unfortu-
nately, at present, precise and very reliable criteria do not exist.
The last word is always to the patient and to his satisfaction.
In conclusion bariatric surgery determines an effective
and long term EWL with a beneficial effect on co-morbidi-
ties. As a consequence life expectancy is lengthened and
quality of life is ameliorated. The social-economic impact is
very effective.
Key points are: correct selection of patients, adequate sur-
gical technique, and exhaustive follow-up.
The laparoscopic approach is, by no means, the gold stan-
dard as it fulfils all criteria to be considered so: safety, efficacy,
reproducibility, cost effectiveness. The efficacy at the 10 years
follow-up will, we are certain, confirm the present results.
However there are a number of controversial “hot topics”
related to:
- age, both for the adolescent and for the elderly; weight
limits (class 1 obesity) for indication to surgery; - criteria for
selection of the type of surgery in the individual patient; -
diabesity; - sleeve gastrectomy. 
In the last few years age limits both on the upper and on
the lower range are under debate. Obesity is extending to
surprising new categories of individuals. Particularly worri-
some is the phenomenon in the paediatric age with per-
centages that go as up as 20-25% between 9 and 12 years of
age. Italy holds first place in Europe, together with Greece.
Fifteen per cent of these children eventually will be morbidly
obese adults.                     
Debate exists also for weight limits (class 1 obesity), since
the ever increasing demand for surgery.
Among the “hot topics”, diabetes and its relationship with
obesity is, at present, the hottest. In the world there are 190
million diabetes mellitus patients, 90% of which are obese.
“Diabesity” is the XXI century epidemic
GBP and BPD seem to exert an anti-diabetic effect, inde-
pendently from the weight loss, determined by an endocrine
mechanism in part clarified, but still needing further inves-
tigation.
The anti-diabetic effect of GBP and BPD is so relevant
that Dixon, in a momentous editorial strongly suggested a
role for surgery in the therapy of DM 2. 
The goal of a surgical therapy for diabetes is pursued by
many surgeons around the world. Trials are ongoing in
Europe, U.S.A. and South America. In the “Diabetes Surgery
Summit (DSS)”, that took place in Rome in March 2007, the
top medical and surgical authorities from all over the world
In 1988 Scopinaro procedure was modified by Hess to
reduce the occurrence of possible troublesome diarrhoea
symptoms. Main differences are: sleeve gastrectomy with
pylorus maintenance, 100 cm common channel: BPD-DS. 
Further Gagner proposed a two steps procedure: first the
sleeve gastrectomy. After an interval of 6-12 months and a
significant EWL, the second step is performed. The two
steps procedure significantly reduces morbidity and mortal-
ity when compared to the one step procedure.
BPD determines a 50-75 % EWL at long (>10 years) fol-
low up, being the most effective procedure on excess weight.
Similarly this procedure is very effective on the metabolic
syndrome (diabetes mellitus 2: 90/100 % resolution, hyper-
cholesterolemia 100 % resolution, etc.
Complications of BPD are: bleeding (6 %), fistulization
(2 %), pulmonary embolism (0.5 %) and respiratory prob-
lems. In most instances the treatment is conservative. Anas-
tomotic ulcers occurrence has been greatly reduced by pro-
ton pomp inhibitors therapy.
Specific side effects of BPD include: tiredness, gas bloat
syndrome, peripheral oedema and, most undesirable, diar-
rhoea (15-20 %) with foul smelling stools.
According to Hess and to Gagner BPD-DS seems to
decrease the incidence of these side effects due to the longer
common channel (100 vs 50 cm) and to the maintenance of
the pylorus. 
Before closing on surgical procedures, only few words on
an old technique with novel interest.  In the last few years the
intra-gastric balloon (BIB) has had an ever increasing popu-
larity among patients and surgeons due to the ease of appli-
cation (endoscopy in sedation), and to encouraging results.
BIB has been used primarily in the treatment of border-
line cases and as a preoperative procedure to decrease ope-
rative risks. 
A randomized study showed that the BIB induced weight-
loss is not a placebo effect but is dependent on a specific mech-
anism. BIB induced in 80% of cases a significant improve-
ment of respiratory function and sleep apnoea episodes.
One problem we are confronted with is the indication of
the type of surgery in the individual patient. In the Nice 2000
EAES consensus conference suggestions have been given. The
criteria adopted take into account well established data.
Although all the three main surgical procedure, more com-
monly executed, determine a significant EWL, this effect
increases from LASGB, to GBP, to BPD. Two additional fac-
tors taken into consideration are: existence of co-morbidities
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defining sleeve gastrectomy a suitable “option” in the treat-
ment of morbid obesity “in particular in patients at high
preoperative risk or in super-super obese patients”. In these
instances sleeve gastrectomy can be considered a “risk reduc-
tion strategy”.
As far as indication for a “tailored” type of operation in
the individual patient, in 2007 we are still in the stone age.
We need criteria that should take into account: behavioural
index, metabolic index, genetic codex and, possibly, allow
us to indicate more correctly and properly what is the best
surgical treatment in the specific patient.
On the other hand therapeutic trials are difficult for a
number of reasons: different social environments determine
different economic conditions, different alimentary habits
and different surgical experiences. Further different genetic
factors and the validation criteria necessitating a long fol-
low-up period make the goal even harder to achieve.
Obesity, appropriately defined “globesity” is, to all
accounts, a social problem. All components of society must
take the burden: - the teaching institutions with an adequate
nutritional education; the National Health System, with effec-
tive preventive campaign, as it has been done for smoking,
and with specific outpatient structures for pre and post-
surgery care; - the media with a correct information avoiding
misleading stories on the so called “malpractice”; - finally
politicians who should not behave like the proverbial three
monkeys: I do not listen, I do not see, I do not talk.
Where are we going and where is the future?
In the last two decades surgeons have been constantly
pursuing the “mini-invasiveness”. On this path another pres-
tigious enterprise has started: Natural Orifice Transluminal
Endoscopic Surgery (N.O.T.E.S.). Trans vaginal, trans gas-
tric cholecystectomies and appendectomies have been per-
formed, intra gastric per-endoscope procedures have been
realized by means of endoscopic suturing devices. In bariatric
surgery the first experimental models of restrictive proce-
dures have been realized. The road is open for exploration.
Will surgery be the ultimate weapon against obesity? Prob-
ably it will not. We are already trespassing from the genetic
engineering (building with genes) to the genetic factory (build-
ing the genes). May be, sometimes in the future we will go from
the laparoscopic mini-invasiveness to the non invasiveness.
In prehistory of man, obesity was a defensive factor, help-
ing the individual to survive through cold winters and famine.
Today obesity has become a global dramatic risk for man. Sur-
gery seems to confront effectively with the problem.
joined to put the basis for future investigational and clinical
studies. The impact of the summit was such that the Ameri-
can Society of Bariatric Surgery (ASBS) has decided to change
the name to ASM(etabolic)BS. A similar decision was taken
by the Italian and other obesity surgery societies.
Diabetes surgery is nowadays a developing reality.
We retrospectively reviewed the results of 110 obese dia-
betic patients, who underwent laparoscopic gastric banding
or gastric by-pass or sleeve gastrectomy with a mean follow
up of 24 months. Regardless of the type of surgical proce-
dure, bariatric surgery cured diabetes in 76, 3% of these
“diabesity” patients. In April 2007 Cohen et al. reported the
preliminary data on two diabetic patients with BMI of 22
and 34 Kg/m², surgically treated with a duodenal-jejunal
by-pass. Patients had normal blood glucose levels 5 weeks
after surgery and were off anti diabetic drugs.
An endo luminal technique has been proposed recently: a
prosthesis (60 cm in length) is anchored to the duodenal bulb,
so preventing contact of ingested food to the duodenal-jeju-
nal mucosa. The ingested food is separate from bilio-pancreatic
juices for all the length of the prosthesis, mimicking a surgical
duodenal-jejunal by-pass. Preliminary results on the resolution
of glucose metabolism alterations are highly promising.
The enthusiasm is great and, may be, a word of caution
may seem appropriate.
In the last few years sleeve gastrectomy (or vertical gas-
trectomy) performed as first step in DS, stimulated a novel
approach to obesity surgery, being proposed by a number of
surgeons as a “solo” procedure.
In a recent summit, in New York City, the results of sleeve
gastrectomy on excess weight and on co-morbidities after a
follow-up of 3 years, have been reported. In collect reviews
(775 patients) the results in terms of EWL (between 33-
83%), morbidity (14%), mortality 0.4 % and the reduction
of co-morbidities were very promising. Disadvantages of
sleeve gastrectomy are: irreversible procedure, postoperative
complications at a very low frequency but, when present, at
high risk. The advantage is that in patients with non satis-
factory results, a second step procedure may be performed
with diminished operative risks. The second procedure may
be multidirectional: D.S. or gastric by pass have been equally
adopted, with relative technical ease.
At present, clinical results of sleeve gastrectomy, as a “pri-
mary solo” procedure, in the treatment of morbid obesity,
encourage to pursue on this path. The American Society for
Metabolic Bariatric Surgery (ASMBS) gave out a statement
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